Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03372720 · ClinicalTrials.gov registry record · NA
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03372720 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 19 participants.
The verdict
NCT03372720, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This randomized pilot trial studies how well fractional carbon dioxide (CO2) laser therapy works in minimizing genitourinary syndrome of menopause (GSM) in gynecological cancer survivors. Fractional CO2 laser therapy may reduce symptoms of GSM in survivors of gynecologic cancers.
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Sham Intervention
- PROCEDURE Laser Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-05-11 |
| Est. Completion | 2022-04-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03372720
The ClinicalTrials.gov registry entry for NCT03372720 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT03372720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03372720 about?
NCT03372720 is a clinical study titled "Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors". This randomized pilot trial studies how well fractional carbon dioxide (CO2) laser therapy works in minimizing genitourinary syndrome of menopause (GSM) in gynecological cancer survivors. Fractional CO2 laser therapy may reduce symptoms of GSM in survivors of gynecologic cancers.
What is the current status of trial NCT03372720?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-05-11. Estimated completion is 2022-04-12.
What interventions are being tested in trial NCT03372720?
The interventions under investigation include: Questionnaire Administration (OTHER), Sham Intervention (PROCEDURE), Laser Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT03372720?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.